Literature DB >> 34227882

Impact of Artificial Intelligence Decision Support Using Deep Learning on Breast Cancer Screening Interpretation with Single-View Wide-Angle Digital Breast Tomosynthesis.

Marta C Pinto1, Alejandro Rodriguez-Ruiz1, Kristin Pedersen1, Solveig Hofvind1, Julia Wicklein1, Steffen Kappler1, Ritse M Mann1, Ioannis Sechopoulos1.   

Abstract

Background The high volume of data in digital breast tomosynthesis (DBT) and the lack of agreement on how to best implement it in screening programs makes its use challenging. Purpose To compare radiologist performance when reading single-view wide-angle DBT images with and without an artificial intelligence (AI) system for decision and navigation support. Materials and Methods A retrospective observer study was performed with bilateral mediolateral oblique examinations and corresponding synthetic two-dimensional images acquired between June 2016 and February 2018 with a wide-angle DBT system. Fourteen breast screening radiologists interpreted 190 DBT examinations (90 normal, 26 with benign findings, and 74 with malignant findings), with the reference standard being verified by using histopathologic analysis or at least 1 year of follow-up. Reading was performed in two sessions, separated by at least 4 weeks, with a random mix of examinations being read with and without AI decision and navigation support. Forced Breast Imaging Reporting and Data System (categories 1-5) and level of suspicion (1-100) scores were given per breast by each reader. The area under the receiver operating characteristic curve (AUC) and the sensitivity and specificity were compared between conditions by using the public-domain iMRMC software. The average reading times were compared by using the Wilcoxon signed rank test. Results The 190 women had a median age of 54 years (range, 48-63 years). The examination-based reader-averaged AUC was higher when interpreting results with AI support than when reading unaided (0.88 [95% CI: 0.84, 0.92] vs 0.85 [95% CI: 0.80, 0.89], respectively; P = .01). The average sensitivity increased with AI support (64 of 74, 86% [95% CI: 80%, 92%] vs 60 of 74, 81% [95% CI: 74%, 88%]; P = .006), whereas no differences in the specificity (85 of 116, 73.3% [95% CI: 65%, 81%] vs 83 of 116, 71.6% [95% CI: 65%, 78%]; P = .48) or reading time (48 seconds vs 45 seconds; P = .35) were detected. Conclusion Using a single-view digital breast tomosynthesis (DBT) and artificial intelligence setup could allow for a more effective screening program with higher performance, especially in terms of an increase in cancers detected, than using single-view DBT alone. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Chan and Helvie in this issue.

Entities:  

Year:  2021        PMID: 34227882     DOI: 10.1148/radiol.2021204432

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Can a Computer-Aided Mass Diagnosis Model Based on Perceptive Features Learned From Quantitative Mammography Radiology Reports Improve Junior Radiologists' Diagnosis Performance? An Observer Study.

Authors:  Zilong He; Yue Li; Weixiong Zeng; Weimin Xu; Jialing Liu; Xiangyuan Ma; Jun Wei; Hui Zeng; Zeyuan Xu; Sina Wang; Chanjuan Wen; Jiefang Wu; Chenya Feng; Mengwei Ma; Genggeng Qin; Yao Lu; Weiguo Chen
Journal:  Front Oncol       Date:  2021-12-17       Impact factor: 6.244

Review 2.  Areas of research to support the system of radiological protection.

Authors:  D Laurier; W Rühm; F Paquet; K Applegate; D Cool; C Clement
Journal:  Radiat Environ Biophys       Date:  2021-10-17       Impact factor: 1.925

3.  Evaluation of a Generative Adversarial Network to Improve Image Quality and Reduce Radiation-Dose during Digital Breast Tomosynthesis.

Authors:  Tsutomu Gomi; Yukie Kijima; Takayuki Kobayashi; Yukio Koibuchi
Journal:  Diagnostics (Basel)       Date:  2022-02-14

Review 4.  Deep learning in breast imaging.

Authors:  Arka Bhowmik; Sarah Eskreis-Winkler
Journal:  BJR Open       Date:  2022-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.